MedTrace Logo

Spy II Clinical Registry

NCT00751998 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 297

Last updated 2021-08-19

Study results available
· View outcomes & findings →

Summary

A prospective, multi-center registry for subjects undergoing Endoscopic retrograde Cholangiopancreatography (ERCP) and cholangioscopy for known or suspected pancreaticobiliary disease.

Conditions

  • Biliary Tract Diseases

Interventions

DEVICE

SpyGlass

The SpyGlass Direct Visualization System is an integrated product platform that is designed to provide a direct intraluminal view of the biliary duct system and direct therapeutic devices.

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Joyce Peetermans, PhD · Boston Scientific Corporation

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-11-30
Primary Completion
2008-04-30
Completion
2009-10-31

Countries

  • United States
  • Belgium
  • Denmark
  • France
  • Germany
  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00751998 on ClinicalTrials.gov